Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Kirin makes and sells beer, soft drinks, food products, and pharmaceuticals to customers in Japan and around the world.
Kirin is a Japanese drinks and health company. Most people know it for beer — it is one of Japan's biggest brewers, and its flagship lager, Ichiban Shibori, is a household staple. But the beer is only part of the story: Kirin also sells soft drinks, food products, and pharmaceuticals, and it earns a growing share of its money outside Japan.

Start with the drinks. Kirin brews beer and makes soft drinks and other beverages, mostly through its Japan-based beverage business. Beer is a mature, slow-growing market in Japan, and the population is aging and drinking less, so the company has been pushing into non-alcoholic drinks and healthier options. Its beer rivals at home include Asahi and Sapporo, and competition is fierce because shelf space and bar taps are limited. The more interesting part is health. Through its pharmaceutical arm, Kyowa Kirin, the company develops and sells prescription medicines, including drugs for cancer and rare diseases. This is a very different business from brewing beer: drug development is slow, expensive, and risky, but a successful medicine can earn high profits for years. Kirin has been shifting toward this side of the business on purpose, because selling beer in Japan no longer grows much.
Kirin also owns a big stake in San Miguel, the Philippine food and beverage group, which gives it exposure to a fast-growing market in Asia. The company pays a steady dividend to shareholders, and like many mature Japanese firms it has faced pressure to use its cash more efficiently. The simple way to see Kirin is this: a reliable Japanese beer and drinks maker that is slowly turning itself into a health and pharmaceuticals company, because the beer business alone is not enough anymore.
Saved answer · last researched 12 Nov 2026